2026.02. 04 本文字数：1284，阅读时长大约2分钟 作者 | 第一财经 李隽 2月4日上午，香港上市的科技股继续遭遇利空，上午恒生科技指数继续跌2.19%，中午报收5347点，截至下午收盘跌逾1.8%；恒生指数下跌0.41%， 中午报收26725点，半天成交1514亿港元，截至收盘则小幅翻红，涨0.05%。 （注：我们会对线索进行核实。您的隐私将严格保密。） 推荐阅读 李亚鹏，一夜卖了1.6亿元茶 光大证券国际策略师伍礼贤向第一财经分析，近日科技股消息较多，2月3日受税收增加传闻影响，2月4日腾讯元宝被接入微信限制也受到市场关注，科 技股市场气氛依然一般，传统经济板块表现可能更为理想，如果美汇指数走弱，对传统经济板块的帮助可能较科技股更为明显。汇丰等国际银行股在当 前环球市场处于历史高点，对其财富管理等业务的帮助较大。 红蚁资本投资总监李泽铭认为，科技股昨日与今日大跌的逻辑有所不同，昨日源于对税务的忧虑，今日则更多受美股估值压力延伸至港股影响。美国人 工智能初创公司推出针对法律服务的AI应用，市场担忧应用可替代市面上部分法律服务软件及SaaS（软件即服务），港股今日跌幅较大的主要为金山 软件、微盟 ...

Core Viewpoint - The central air conditioning industry is undergoing an adjustment period due to declining traditional engineering demand, prompting companies like Gree Electric and Midea Group to invest more resources in AI data center cooling and high-performance infrastructure to seek structural growth opportunities [5][6]. Group 1: Market Dynamics - Air conditioning still accounts for about 70% of Gree Electric's revenue, with central air conditioning being a core segment. However, the industry faces pressure from a downturn in real estate, weak traditional engineering demand, and intensified price competition [7]. - In 2025, the sales scale of China's central air conditioning industry is projected to be 138.68 billion yuan, with a 7.4% year-on-year decline in the domestic market, while the export market is expected to grow by 12.7%. The growth in exports is significantly driven by ongoing investments in overseas data centers and computing infrastructure [7]. Group 2: Technological Trends - As AI computing power increases, the power density of server cabinets is rising rapidly, revealing limitations in traditional air cooling solutions in terms of efficiency and heat dissipation. Liquid cooling is gradually becoming an important technology route for high-performance data centers [8]. - Liquid cooling is not merely an equipment upgrade but involves comprehensive changes in system architecture, core components, and operational modes. It is seen as a supplementary solution in high-performance scenarios, often coexisting with air cooling solutions, requiring higher system integration and project experience [8]. Group 3: Competitive Landscape - The data center cooling market is primarily dominated by two types of companies: specialized manufacturers with extensive experience in data center temperature control, such as Vertiv, Ingersoll Rand, and others, and foreign brands like Johnson Controls and Carrier, alongside domestic central air conditioning manufacturers like Gree and Midea [10]. - Domestic central air conditioning companies face significant challenges in the data center market, including the maturity of technology in high-performance scenarios, the ability to deliver complex projects, and the long verification cycles required by leading clients [10]. Group 4: Future Outlook - Overall, AI data center cooling presents a rare structural growth opportunity for the central air conditioning industry, but its scale, pace, and profit model differ significantly from traditional engineering markets. In the short term, data center business serves more as a buffer against the decline of traditional business rather than a decisive replacement [11]. - The ability of companies like Gree and Midea to establish stable engineering capabilities and long-term customer relationships in high-barrier technology paths like liquid cooling will be crucial in determining their position in the computing infrastructure cycle [11].

Core Viewpoint - The article discusses the recent legal challenges faced by Elon Musk's companies, particularly X Corp and its AI subsidiary xAI, due to concerns over the dissemination of harmful content and the use of personal data, highlighting the strict regulatory environment in Europe compared to the U.S. [3][6][10] Group 1: Legal Actions and Investigations - On February 3, 2026, X Corp's Paris office was raided by authorities amid concerns over the AI chatbot Grok generating controversial images, leading to public protests [3][6] - The French prosecutor's office stated that the investigation aims to ensure X Corp complies with French laws, while X Corp denied any wrongdoing and criticized the raid as a political attack [7][10] - The UK Information Commissioner's Office (ICO) has also launched an investigation into X Corp and xAI regarding the use of personal data and the generation of harmful content [6][8] Group 2: Regulatory Environment in Europe - Europe, particularly France, has a history of strict regulations against U.S. tech giants, with recent actions reflecting a push for "digital sovereignty" [3][10] - The European Parliament has passed resolutions supporting the development of European cloud platforms and AI models, indicating a shift towards prioritizing local technology solutions [10] - France's government has mandated the transition to domestically developed video conferencing solutions by the end of 2026, emphasizing the need for secure and stable public electronic communications [10] Group 3: Impact on Musk's Companies - xAI has implemented measures to prevent Grok from generating unauthorized deepfake content, responding to regulatory pressures [9] - The ongoing investigations and regulatory scrutiny may exacerbate tensions between the U.S. and Europe regarding tech regulations, as highlighted by Musk's previous criticisms of European policies [10] - The merger of xAI with SpaceX has resulted in a combined valuation of $1.25 trillion, indicating significant financial stakes amid the regulatory challenges [9]

2026.02. 04 本文字数：1515，阅读时长大约3分钟 分行业来看，全球工业与服务业领域有14%的受访企业将中国内地列为前三大投资目的地，较上年上升；能源、公用事业与资源行业次之，比例由上年 的10%升至13%；消费市场比例持平。除医疗健康行业较上年略有下降外，其他大部分行业的这一比例均有所提升。 在全球科技竞争加剧与AI（人工智能）变革提速的浪潮中，创新已成为中企应对不确定性的首要议题，18%的内地和22%的香港CEO最关心公司的创新 能力是否足以应对充满不确定性的未来。中企已将创新置于战略核心，并展现出领先全球的执行力度，其创新实践的整体推进力度远超全球平均水平。 作者 | 第一财经 缪琦 虽然中国企业家当前及短期面临一定的营收压力，但对未来三年持乐观态度。 普华永道于2月4日发布的《第29期全球CEO调研中国报告：创新突围 韧性生长》（下称"报告"）显示，中国CEO（内地及香港）对于未来一年全球经 济增长的信心领跑全球，连续三年上调对全球经济增长的预期。其中，67%看好未来12个月全球经济增速持续回升，信心水平高于61%的全球平均水 平。 普华永道中国公共事务主管合伙人周星表示，全球企业家对于短 ...

Core Viewpoint - The article discusses the synergy between domestic chip companies and cloud service providers in Shanghai, emphasizing the need for collaboration to advance AI applications in various sectors such as autonomous driving and biomedicine [3][19]. Group 1: Shanghai's Chip Industry Development - Shanghai's domestic chip industry is more mature compared to other cities in China, with significant government support and a high concentration of AI companies [6]. - In 2025, Shanghai's integrated circuit industry revenue is expected to exceed 480 billion yuan, with 35 companies listed on the Sci-Tech Innovation Board, the highest in the country [9]. - Major local chip companies like Wallen, Muxi, and Tensu Zhixin have recently gone public, breaking down barriers between technology and capital markets [9][10]. Group 2: AI Chip Ecosystem and Challenges - Despite the growth of local AI chip companies, the industry faces challenges due to reliance on NVIDIA's ecosystem, which dominates AI software development [14][18]. - The lack of a unified development platform for heterogeneous computing limits the adoption of domestic chips, as developers are often tied to specific software architectures [15][17]. - There is a need for a standardized approach to enhance compatibility and efficiency across different chip platforms [16]. Group 3: Future Prospects and Strategies - The process of domestic computing power localization is expected to continue through 2026, with ongoing advancements in AI models and competitive pricing compared to U.S. counterparts [23][24]. - Domestic chip companies should focus on identifying more application scenarios to increase the usage of local chips, aiming for international markets as well [25]. - Collaboration with ASEAN and Central Asian countries is suggested to build an international supply chain for computing power, promoting domestic GPU solutions abroad [26].

Core Viewpoint - The article emphasizes the critical role of energy in driving civilization and highlights the ongoing energy revolution, which is transitioning from fossil fuels to renewable energy sources like wind and solar power [2][3]. Group 1: Energy Revolution - The energy revolution is compared to historical shifts in human civilization, marking a transition from fossil energy to renewable sources [2]. - The cost reduction in sustainable energy solutions is a key catalyst for this revolution, making them economically viable compared to traditional energy sources [3]. Group 2: Market Trends and Predictions - By 2025, China's new power generation capacity is expected to reach 550 million kilowatts, with wind and solar accounting for 440 million kilowatts, representing 80.2% of the total new capacity [3]. - The share of renewable energy sources in new electricity consumption is projected to be 97.1%, indicating a significant shift towards green energy [3]. Group 3: Technological Advancements - The cost of lithium iron phosphate (LFP) batteries and solar energy has decreased by approximately 80% over the past decade, facilitating the transition to renewable energy [4]. - Despite advancements, there is still a considerable gap in achieving a fully sustainable energy system, with only about 30% of key technologies currently developed [4]. Group 4: Global Collaboration and Solutions - Ningde Times aims to promote sustainable energy solutions globally through a technology licensing model, which has already been implemented in collaboration with Ford in the U.S. [4]. - The establishment of "zero-carbon economic zones" is proposed to facilitate the sharing of best practices and regulatory frameworks similar to those in China [5]. Group 5: Future Energy Trends - The future energy system is predicted to evolve towards three main trends: distributed generation, intelligence, and circular economy, with 2030 being identified as the beginning of the sustainable energy era [6].

Core Viewpoint - The article discusses the penalty imposed on the probiotic brand Junxiaobao and its distributor Meihui Biotechnology (Shanghai) Co., Ltd. for false advertising regarding their product "Space No. 30," which was claimed to have therapeutic effects that it does not possess [2][4]. Group 1: Company Overview - Junxiaobao is a probiotic brand represented by celebrity Jia Nailiang, and its parent company is Chenguan Group [6][8]. - The company was established in May 2019 with a registered capital of approximately 200 million RMB, focusing on the sale of maternal and infant products, clothing, and daily necessities [8][11]. Group 2: Regulatory Actions - On June 18, 2025, the company promoted "Space No. 30" through a live broadcast, making unverified claims about its effectiveness in treating various gynecological issues [2][4]. - The Shanghai Chongming District Market Supervision Administration found that the product is an ordinary food item and does not have the claimed therapeutic effects, leading to a fine of 30,000 RMB imposed on December 3, 2025 [4][6]. Group 3: Company Response and Communication - Attempts by reporters to contact Meihui Biotechnology were unsuccessful, and the official customer service of Junxiaobao stated that probiotics are not medicines but are meant for auxiliary use [6][8].

Market Overview - On February 4, the Hong Kong Hang Seng Index rose by 0.05% to close at 26,847.32, while the Hang Seng Tech Index fell by 1.84% to 5,366.44 [1][2]. Technology Sector Performance - The technology sector continued its poor performance, with notable declines in several companies: Kingdee International dropped over 12%, Trip.com fell over 6%, and Tongcheng Travel decreased by more than 5%. Tencent Holdings, Bilibili, and NetEase all saw declines exceeding 3% [2][3]. Semiconductor Sector Performance - The semiconductor sector experienced significant declines, with Naxin Micro falling over 6%, Tianyu Semiconductor down over 6%, and Shanghai Fudan dropping over 5%. Other companies like Huahong Semiconductor and Zhaoyi Innovation also reported declines of nearly 5% and over 3%, respectively [3][4]. Coal Sector Activity - Coal stocks were active, with Yancoal Australia rising over 10%, China Shenhua increasing by over 5%, and Zhongmei Energy up by over 8% [5][6]. Real Estate Sector Performance - The domestic real estate sector saw substantial gains, with Shimao Group increasing by over 14%, New World Development rising over 10%, and Sunac China up by over 8%. Vanke Enterprises also reported an increase of over 6% [7][8].

Core Viewpoint - The article discusses the recent fluctuations in gold prices and the implications for gold accumulation products, highlighting the risks associated with these investments as they are perceived as low-risk alternatives for inflation protection by some investors [3][6]. Group 1: Gold Accumulation Products - Gold accumulation is a service offered by banks that allows customers to open gold accounts and record the weight of gold deposited over time, gaining popularity during rising international gold prices [6]. - These products are characterized by low entry barriers, ease of operation, and the ability to redeem physical gold, making them attractive to risk-averse investors [6][7]. - Recent volatility in gold prices has led banks to adjust their gold accumulation services, including raising entry thresholds and enhancing risk warnings to clients [7]. Group 2: Market Volatility and Risk Management - The article notes significant daily fluctuations in international gold prices, prompting banks to take measures to mitigate liquidity risks and filter out investors with lower risk tolerance [7][10]. - Banks have raised the minimum investment amount for gold accumulation products, with some requiring specific risk assessment results for clients to engage in all services [7]. - The article emphasizes that gold accumulation is not a zero-risk investment, as the value of assets can decrease during price drops, and it is more suitable for long-term investors rather than short-term traders [10][11]. Group 3: Investor Awareness and Education - There is a need for better communication from banks regarding the nature of gold accumulation products, particularly the limitations on redeeming physical gold and the associated costs [11]. - Investors often misunderstand the terms related to redeeming physical gold, leading to potential dissatisfaction and financial loss [11]. - The article suggests that banks should provide clearer information on market volatility triggers and risk management conditions to help investors make informed decisions [10][11].

Core Viewpoint - Novo Nordisk's flagship product, semaglutide, achieved a total sales revenue of 228.29 billion Danish Krone (approximately 250.84 billion yuan) in 2025, marking a growth of over 10% year-on-year [3]. Group 1: Product Performance - The sales breakdown for semaglutide includes: - Ozempic (diabetes version) with sales of 127.09 billion Danish Krone - Wegovy (weight loss version) with sales of 79.11 billion Danish Krone - Oral semaglutide (diabetes version) with sales of 22.09 billion Danish Krone [3]. - In the Chinese market, the total sales for the three series of semaglutide products reached 6.81 billion Danish Krone (approximately 7.49 billion yuan) [4]. Group 2: Financial Overview - Novo Nordisk's overall revenue for the year was 309.06 billion Danish Krone, reflecting a year-on-year growth of 6%, and a growth of 10% when adjusted for constant exchange rates [5]. - The net profit for the company was 102.43 billion Danish Krone, showing a year-on-year increase of 1% [5]. Group 3: Challenges and Market Dynamics - 2026 poses significant challenges for Novo Nordisk as the core compound patent for semaglutide will expire in some international markets, including China on March 20, 2026, leading to potential price competition from generic drugs [5]. - There are currently 10 applications for semaglutide generics filed in the Chinese market, with an additional 11 in Phase III clinical trials [6]. Group 4: Strategic Responses - In response to the patent expiration, Novo Nordisk plans to launch an oral GLP-1 weight loss drug, Wegovy tablets, which received approval in the U.S. in December 2025 and was launched on January 5, 2026, with a weekly prescription volume of approximately 50,000 as of January 23, 2026 [6][7]. - The company is also working on a stronger weight loss GLP-1 drug, having submitted new drug applications for a 7.2 mg semaglutide injection and CagriSema, a combination of cagrilintide and semaglutide, which showed a weight loss of 22.7% over 68 weeks in trials [7]. Group 5: Market Outlook - The global GLP-1 market is expected to continue expanding, and Novo Nordisk's new therapies aim to broaden patient coverage and increase sales [8].